Author

Ekaterina Rozhavskaya

ORCID 0009-0004-8910-2536Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Alex J. CornishiD· 2 shared Almoatazbellah YoussefiD· 2 shared Markus EcksteiniD· 2 shared Alberto RomagnoniiD· 1 shared Alice Mac KainiD· 1 shared Almudena Espín-PéreziD· 1 shared Anna Christina SchaariD· 1 shared Arndt HartmanniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alex J. CornishORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 15, 2026

Identification of non-covalent inhibitors for the atypical peroxiredoxin PRDX5 as a therapeutic strategy in malignant pleural mesothelioma

Josep Monserrat, Floriane Montanari, Victor Laurent…·Elodie Pronier

The paper identifies non-covalent inhibitors of PRDX5, a protein upregulated in MPM, through a machine learning guided pipeline and biochemical validation, suggesting it as a therapeutic target.

DOI 10.64898/2026.05.13.724787

humanproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintMar 13, 2026

Multi-modal benchmarking of the Ultima UG100 and Illumina NovaSeq sequencing platforms using clinically relevant FFPE tissues

Quentin Bayard, Zelda Mariet, Anna Christina Schaar…·Almudena Espín-Pérez

This paper benchmarks the Ultima UG100 and Illumina NovaSeq platforms on FFPE tissues for various sequencing modalities, finding they produce comparable results with subtle discrepancies in non-coding transcripts.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky